My research centers on clinical and molecular hepatology, pharmacogenomics, and omics-based approaches, withparticular emphasis on metabolic-dysfunction associated steatotic liver disease (MASLD), also known as fatty liver disease. I amactively engaged in advancing research on MASLD with a focus on translational applications in primary care settings.Currently, I am a part of a multidisciplinary team addressing various MASLD populations, including MASLD in individuals livingwith HIV and chronic kidney disease.